2022
DOI: 10.1213/ane.0000000000006001
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative Precision Medicine and Bedside Decision Making: Still a Case of Great Expectations?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…5 Future trials will not only include patient clinical data and procedure information but genomics, pharmacogenetics, epigenetic data, and more. 6 Patient-level pharmacogenetic data may ultimately be able to tell us the optimal drug regimen and optimal dosage of each drug to prescribe a given patient for anxiolysis, analgesia, anesthesia, and antiemetic prophylaxis based upon his or her unique genetic profile. 7 This evolution is tied closely to advances in machine learning, artificial intelligence, and implementation science.…”
Section: Jama Networkmentioning
confidence: 99%
See 1 more Smart Citation
“…5 Future trials will not only include patient clinical data and procedure information but genomics, pharmacogenetics, epigenetic data, and more. 6 Patient-level pharmacogenetic data may ultimately be able to tell us the optimal drug regimen and optimal dosage of each drug to prescribe a given patient for anxiolysis, analgesia, anesthesia, and antiemetic prophylaxis based upon his or her unique genetic profile. 7 This evolution is tied closely to advances in machine learning, artificial intelligence, and implementation science.…”
Section: Jama Networkmentioning
confidence: 99%
“…Randomized, embedded, multifactorial, adaptive platform (REMAP) trials are well suited to ERAS protocols and can test multiple interventions simultaneously . Future trials will not only include patient clinical data and procedure information but genomics, pharmacogenetics, epigenetic data, and more . Patient-level pharmacogenetic data may ultimately be able to tell us the optimal drug regimen and optimal dosage of each drug to prescribe a given patient for anxiolysis, analgesia, anesthesia, and antiemetic prophylaxis based upon his or her unique genetic profile .…”
mentioning
confidence: 99%